FIELD: medicine.
SUBSTANCE: present invention refers to medicine and describes a method for preparing a tablet exhibiting antihypertensive activity containing a) an active substance containing valsartan 80 or 160 mg or its pharmaceutically acceptable salt, and hydrochlorothiazide (HCTZ) 12.5 or 25 mg; b) pharmaceutical acceptable additives suitable for preparing tablets by compression wherein said method involves the stages, I) grinding of the active substance which contains said valsartan and said hydrochlorothiazide, and pharmaceutically acceptable additives; II) compression of a mixture of the grinded active substance and additives with making a comprimate with said compression for making the comprimate requires compaction of the dry mixture of the grinded ingredients; III) transformation of the comprimate into a granulate having a particle size distribution 9 to 340 micron; and IV) compression of the granulate with preparing the tablet.
EFFECT: method provides preparing the tablet possessing intensified antihypertensive activity.
4 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
VALSARTAN-BASE SOLID ORAL DOSING FORMULATIONS | 1997 |
|
RU2294743C2 |
SOLID ORAL DOSED VALSARTAN-BASED FORMS | 1997 |
|
RU2203054C2 |
PHARMACEUTICAL COMPOSITIONS | 2001 |
|
RU2333757C2 |
GALENA COMPOSITION OF ALISKIREN AND HYDROCHLOROTHIAZIDE | 2007 |
|
RU2491058C2 |
SOLID PERORAL DOSED OUT FORMS OF VALSARTAN | 2005 |
|
RU2361575C2 |
DIPHOSPHONIC ACID-CONTAINING COMPOSITIONS | 1999 |
|
RU2207860C2 |
USING RECEPTOR AT-1 ANTAGONIST OR RECEPTOR AT-2 MODULATOR IN TREATMENT OF DISEASES ASSOCIATED WITH INCREASE CONTENT OF AT-1 OR AT-2 RECEPTORS | 1999 |
|
RU2271809C2 |
PHARMACEUTICAL COMPOSITION OF DIURETIC, DEHYDRATING AND HYPOTENSIVE ACTION | 2002 |
|
RU2201753C1 |
SOLID DOSAGE FORMS OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE AND METHOD FOR MAKING THEM | 2007 |
|
RU2449786C2 |
CEFUROXIMAXETIL-CONTAINING COMBINATIONS | 1999 |
|
RU2248794C2 |
Authors
Dates
2012-06-20—Published
2007-01-10—Filed